Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combined antidepressants: clinical experience.

J E Rojo1, S Ros, L Agüera

  • 1Hospital Universitàri de Bellvitge, L'Hospitalet de Llobregat, Madrid, Spain. jrojo@csub.scs.es

Acta Psychiatrica Scandinavica. Supplementum
|November 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.

Oncogene·2026
Same author

Towards a consensus on training for advance care planning in mental health: Results from a Delphi study.

International journal of law and psychiatry·2026
Same author

Incidence and Survival of IDH-Wildtype Glioblastoma and IDH-Mutant Astrocytoma by Treatment and Sex: A Regional Study in Spain (2011-2021).

Medical sciences (Basel, Switzerland)·2025
Same author

Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients.

Scientific reports·2024
Same author

Consensus Statement on the Psychological Needs of Patients With Chronic Inflammatory Skin Diseases.

Actas dermo-sifiliograficas·2018
Same author

Paradoxical Arthritis Due to Ixekizumab in a Patient With Plaque Psoriasis.

Actas dermo-sifiliograficas·2018

Combining antidepressant medications, such as selective serotonin reuptake inhibitors (SSRIs) or SSRIs with bupropion, may speed up treatment response. Further clinical trials are needed to confirm benefits and develop guidelines for antidepressant combinations.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Medicine

Background:

  • Antidepressant monotherapy is a common treatment for depression.
  • Challenges in achieving adequate response with single agents necessitate exploring combination therapies.

Purpose of the Study:

  • To review existing literature on the efficacy and recommendations for combining antidepressant agents.
  • To identify current trends and evidence supporting antidepressant combination therapy.

Main Methods:

  • Comprehensive literature searches were conducted.
  • Review of various data sources including surveys, prescription records, decision algorithms, clinical reports, and comparative studies.

Main Results:

  • Surveys suggest combining selective serotonin reuptuptake inhibitors (SSRIs), or SSRIs with bupropion or dual-action antidepressants.

Related Experiment Videos

  • Decision algorithms recommend combinations like SSRI plus tricyclic antidepressant (TCA), or bupropion plus venlafaxine/mirtazapine.
  • Limited controlled trials exist, but some report benefits for combinations such as TCAs plus mianserin or SSRIs plus mirtazapine.

    • Conclusions:

    • Combining antidepressants can potentially accelerate treatment onset and sustain patient response.
    • There is a need for more rigorous clinical trials comparing combination therapy with monotherapy.
    • Development of evidence-based guidelines for rational antidepressant combination therapy is required.